Retrotope

About:

Retrotope is a developer of a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases.

Website: http://www.retrotope.com

Top Investors: Morningside Venture Investments, Life Science Angels, Green Park & Golf Ventures, North Texas Angel Network, SDL Ventures

Description:

Retrotope creates a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. It is a privately held company focused on the development of ways of controlling metabolic processes associated with oxidative stress conditions. Retrotope uses isotope effect to slow down damaging pathways. The company has several discovery and development programs that involve major classes of biopolymers, with the major focus on neurological diseases such as Friedreich's ataxia. It was founded in 2006 and is located in Los Altos Hills, California.